Basel Medical Group Ltd Ordinary Shares
Price Action
Technical Summary
WEAKENINGBasel Medical Group Ltd Ordinary Shares is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 20), showing significant lag compared to the market leaders. Investors should exercise caution due to high volatility (174% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $7.04 | -3.48% | BELOW |
| 50 SMA | $7.41 | -8.24% | BELOW |
| 100 SMA | $7.38 | -7.90% | BELOW |
| 150 SMA | $8.18 | -16.91% | BELOW |
| 200 SMA | $10.95 | -37.90% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BMGL in an uptrend right now?
BMGL has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is BMGL overbought or oversold?
BMGL's RSI (14) is 46. The stock is in neutral territory, neither overbought nor oversold.
Is BMGL outperforming the market?
BMGL has a Relative Strength (RS) Rating of 20 out of 99. BMGL is currently lagging the broader market.
Where is BMGL in its 52-week range?
BMGL is trading at $6.80, which is 12% of its 52-week high ($54.60) and 11% above its 52-week low ($0.79).
How volatile is BMGL?
BMGL has a Beta of 0.90 and 52-week volatility of 174%. It's less volatile than the S&P 500 - generally more stable.